AMGEN INC — Director's Dealing 2023

Aug 22, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2023-08-14

Reporting Person: Busch Matthew C. (VP, Finance & CAO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4596	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nqso (Right to Buy)	$177.46	2028-04-27	Common Stock (1257)		Direct
Nqso (Right to Buy)	$177.31	2029-05-03	Common Stock (1476)		Direct
Nqso (Right to Buy)	$236.36	2030-05-05	Common Stock (1558)		Direct
Nqso (Right to Buy)	$239.64	2031-04-30	Common Stock (1086)		Direct
Nqso (Right to Buy)	$230.92	2032-05-02	Common Stock (1753)		Direct
Nqso (Right to Buy)	$235.97	2033-05-02	Common Stock (2508)		Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 64 RSUs which will vest on 5/5/2024; 84 RSUs which will vest in installments of 41 on 4/30/2024 and 43 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 1,496 RSUs which will vest in installments of 493 on 11/5/2023, 494 on 11/5/2024 and 509 on 11/5/2025; 214 RSUs which will vest in installments of 70 on 5/2/2024, 71 on 5/2/2025, and 73 on 5/2/2026; and 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include 126 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F3: 1,257 of these non-qualified stock options have vested and are exercisable.

F4: 1,476 of these non-qualified stock options have vested and are exercisable.

F5: 1,028 of these non-qualified stock options have vested and 530 will vest and become exercisable on 5/5/2024.

F6: 358 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in installments of 358 on 4/30/2024 and 370 on 4/30/2025.

F7: These non-qualified stock options will vest and become exercisable in two installments of 578 on 5/2/2024 and 5/2/2025 and one installment of 597 on 5/2/2026.

F8: These non-qualified stock options will vest and become exercisable in installments of 827 on 5/2/2025, 828 on 5/2/2026 and 853 on 5/2/2027.